CEOs of rare disease companies
Name | Description | Birthdate | Birthplace | ||
|---|---|---|---|---|---|
Member of the Board. Chair of the R&D Committee. Member of the Remuneration Committee. | |||||
Founder of Recursion Pharma | |||||
CEO of Sanofi | |||||
CEO of Homology Medicines & Agilis Biotherapeutics Inc. | |||||
CEO & former CEO of Moderna Therapeutics | |||||
CEO of Moderna Therapeutics | |||||
Brigette Roberts, M.D. is the chief executive officer (CEO) and a director at OrphAI Therapeutics. | |||||
CEO of Bluebird Bio, 2seventy bio & 2seventy bio, Inc. | |||||
founder & CEO of Healx | |||||
founder & CEO of Dicerna Pharmaceuticals | |||||
CEO of PTC Therapeutics | |||||
founder & CEO of Hyperion Therapeutics | |||||
CEO of Disc Medicine | |||||
founder & CEO of Arthex Biotech | |||||
founder of ViThera Pharmaceuticals, based in Massachusetts | |||||
French businessman | |||||
founder & CEO of Syntis Bio | |||||
founder & CEO of InnoSkel | |||||
CEO of Inozyme Pharma | |||||
CEO of MyoKardia | |||||
CEO of Entrada Therapeutics | |||||
CEO of Imara | |||||
founder & CEO of Inventiva Pharma | |||||
CEO of Passage Bio, Inc. | |||||
founder & CEO of Mendelian Ltd |
